Germany, Sept. 4 -- Germany based Octapharma GmbH has secured contract from AOK Sachsen - Anhalt for Pharmaceutical products - drug discount agreement according to Section 130a Paragraph 8 SGB V in conjunction with Section 130c Paragraph 1 SGB V for the drugs Nuwiq (B02BD02), Octanate (B02BD02), Octanine F (B02BD04) and Wilate (B02BD06) for hemophilia . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....